Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 10 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-10-21 4 OE $12.99 $25,980 I/I 2,000 48,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-10-24 4 OE $12.99 $25,980 I/I 2,000 48,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-11-25 4 OE $12.99 $25,980 I/I 2,000 45,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-10 4 OE $12.99 $25,980 I/I 2,000 45,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-11-18 4 S $25.99 $25,988 D/D (1,000) 93,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-07 4 OE $26.49 $26,490 D/D 1,000 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-07-23 4 OE $17.86 $26,790 D/D 1,500 286,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-04 4 OE $17.86 $26,790 D/D 1,500 286,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-10-03 4 OE $17.86 $26,790 D/D 1,500 287,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-02 4 OE $17.86 $26,790 D/D 1,500 289,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-25 4/A S $26.94 $26,944 D/D (1,000) 130,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-25 4 S $26.94 $26,944 D/D (1,000) 103,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-11-23 4 S $27.02 $27,021 D/D (1,000) 93,567 0 -
IMNM Immunome Inc.   –       •      –    2024-05-21 4 B $13.57 $27,140 D/D 2,000 9,615 0.01 %
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-12-06 4 S $27.17 $27,174 D/D (1,000) 93,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-12-13 4 S $27.43 $27,429 D/D (1,000) 93,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-12-22 4 AS $18.83 $28,245 D/D (1,500) 53,940 0 -
PTLA Portola Pharmaceuticals I... Director   –       •      –    2013-05-22 4 B $14.50 $29,000 D/D 2,000 2,000 2.39 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-03 4 OE $9.86 $29,580 D/D 3,000 94,893 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-10-12 4 OE $9.86 $29,580 D/D 3,000 180,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-10-22 4 OE $9.86 $29,580 D/D 3,000 178,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-10-31 4 OE $9.86 $29,580 D/D 3,000 178,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-07 4 OE $9.86 $29,580 D/D 3,000 170,691 0 -
NGSX Neurogesx Inc Director   –       •      –    2009-08-17 4 S $7.21 $29,844 D/D (4,119) 20,621 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-07-14 4 AS $30.00 $30,000 D/D (1,000) 131,093 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10  11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 10 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us